BUSINESS

Oruka Therapeutics (ORKA) Reports Positive Phase 2a Results for Psoriasis Treatment ORKA-001

Apr 30, 2026 - 17:00
Oruka Therapeutics (ORKA) Reports Positive Phase 2a Results for Psoriasis Treatment ORKA-001
Read More

Tags:

Previous Article

Fastly (FSLY), LALIGA Partner on AI-Driven Real-Time Anti-Piracy Project

Next Article

Is Spyre Therapeutics (SYRE) One of the Small-Cap Stocks That Are On Fire Right ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Jim Cramer on Berkshire Hathaway: “To Leave the Stock Now Is a Big Mistake”

Jim Cramer on Berkshire Hathaway: “To Leave the Stock N...

Apr 24, 2026

Will Q1 Earnings Power GE Vernova Stock to $1,225?

Will Q1 Earnings Power GE Vernova Stock to $1,225?

Apr 23, 2026

Analyst Report: Invesco Ltd

Analyst Report: Invesco Ltd

Apr 29, 2026